Neurology

From stroke to neurodegeneration — the science and its clinical impact.

NeuroMark dFNC aims to standardize dynamic fMRI states across datasets

NeuroMark dFNC proposes transferable dynamic-state templates for resting-state fMRI, aiming to make chronnectomics comparable across studies and subjects.

By Dr. A. Manasa, MBBS · Oct 25, 2026 · 5 min read

Neurology·bioRxiv

Multimodal Glymphatic Imaging in Multiple Sclerosis Targets Sleep and Disability

A preprint examines glymphatic imaging in multiple sclerosis, linking sleep biology and disability to a fluid-clearance pathway under…

Oct 25, 2026

Neurology·BMJ

Stroke prevention intervention hinges on fidelity, group support, and staff skill

Process evaluation of a Swedish stroke prevention program found good overall fidelity, but attendance, app usability, and staff…

Oct 25, 2026

Neurology·NIH

Extra Year of School Linked to Lower Dementia Risk Later in Life

NIH-funded analysis links a UK schooling reform to lower dementia incidence decades later, with the largest benefit in…

Oct 25, 2026

Neurology·Cancer Cell

PSMF1 Variants Link Parkinsonism, Neurodegeneration and Perinatal Lethality

Biallelic PSMF1 variants were tied to a spectrum from early-onset parkinsonism to perinatal lethality, with proteasomal and mitochondrial…

Oct 25, 2026

Neurology·FDA

FDA De Novo listing places BrainScope Ahead 100 in device registry

FDA’s De Novo database lists BrainScope Ahead 100, a novel device from Brainscope Company, with decision date November…

Oct 25, 2026

Neurology·Nature

Conversational AI may help patients fine-tune epilepsy seizure detectors

A small study suggests patients can help adjust seizure detectors through conversation with AI, but safe, appropriate responses…

Oct 25, 2026

Neurology·bioRxiv

DRPLA Mouse Model Shows Epilepsy and ASO Disease Modification

A humanized DRPLA mouse model reproduced seizure vulnerability and early death, while antisense oligonucleotide treatment improved seizure and…

Oct 25, 2026

Neurology·Lancet ID

Multiple sclerosis genetics extends beyond risk to severity and progression

Genetic studies in multiple sclerosis clarify immune mechanisms, but predictive value for disability and progression remains limited in…

Oct 25, 2026

Neurology·ACC-PRO

BMS leads Pathos AI’s $237M Series E in Alzheimer’s push

Bristol Myers Squibb led Pathos AI’s $237 million Series E as the companies and Tempus launched an Alzheimer’s-focused…

Oct 25, 2026

Neurology

From stroke to neurodegeneration — the science and its clinical impact.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.